In today’s news reports we cover items on:
- Prediction of risk for prostate cancer under-grading based on biopsy data
- The obesity/risk equation in prostate cancer
- Capecitabine + docetaxel in metastatic CRPC … READ MORE …
Filed under: Diagnosis, Drugs in development, Management, Risk, Treatment | Tagged: biopsy, capecitabine, CRPC, docetaxel, Gleason score, obesity, risk, under-grading | Leave a comment »
